The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Open accessAbstract
Outbreaks of emerging infections present health professionals with the unique challenge of trying to select appropriate pharmacologic treatments in the clinic with little time available for drug testing and development. Typically, clinicians are left with general supportive care and often untested convalescent-phase plasma as available treatment options. Repurposing of approved pharmaceutical drugs for new indications presents an attractive alternative to clinicians, researchers, public health agencies, drug developers, and funding agencies. Given the development times and manufacturing requirements for new products, repurposing of existing drugs is likely the only solution for outbreaks due to emerging viruses. In the studies described here, a library of 290 compounds was screened for antiviral activity against Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV). Selection of compounds for inclusion in the library was dependent on current or previous FDA approval or advanced clinical development. Some drugs that had a well-defined cellular pathway as target were included. In total, 27 compounds with activity against both MERS-CoV and SARS-CoV were identified. The compounds belong to 13 different classes of pharmaceuticals, including inhibitors of estrogen receptors used for cancer treatment and inhibitors of dopamine receptor used as antipsychotics. The drugs identified in these screens provide new targets for in vivo studies as well as incorporation into ongoing clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
The American Society of Health System Pharmacists
Beard, E. L. (2001) · JONA's Healthcare Law, Ethics, and Regulation · doi:10.1097/00128488-200109000-00003 · Cited by 1,678
de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01244-13 · Cited by 1,236
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Self-citationMolecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., Zhang, Y., Zhang, W., Yuan, Y., Bao, J., et al. (2013) · Nature · doi:10.1038/nature12328 · Cited by 739
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736
Reusken, C. B., Haagmans, B. L., Müller, M. A., Gutierrez, C., Godeke, G.-J., Meyer, B., Muth, D., Raj, V. S., Vries, L. S.-D., Corman, V. M., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70164-6 · Cited by 734
Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia
Memish, Z. A., Mishra, N., Olival, K. J., Fagbo, S. F., Kapoor, V., Epstein, J. H., AlHakeem, R., Durosinloun, A., Al Asmari, M., Islam, A., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1911.131172 · Cited by 716
Coyne, C. B., & Bergelson, J. M. (2006) · Cell · doi:10.1016/j.cell.2005.10.035 · Cited by 547
American Society of Health-System Pharmacists
(2016) · The SAGE Encyclopedia of Pharmacology and Society · doi:10.4135/9781483349985.n33 · Cited by 510
Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
Alagaili, A. N., Briese, T., Mishra, N., Kapoor, V., Sameroff, S. C., de Wit, E., Munster, V. J., Hensley, L. E., Zalmout, I. S., Kapoor, A., et al. (2014) · mBio · doi:10.1128/mbio.00884-14 · Cited by 476
Self-citationRapid generation of a mouse model for Middle East respiratory syndrome
Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S. S., Fett, C., Zhao, J., Gale, M. J., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 452
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., Herman, B. D., Sheahan, T., Heise, M., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat, South Africa
Ithete, N. L., Stoffberg, S., Corman, V. M., Cottontail, V. M., Richards, L. R., Schoeman, M. C., Drosten, C., Drexler, J. F., & Preiser, W. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1910.130946 · Cited by 381
Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and Europe
Annan, A., Baldwin, H. J., Corman, V. M., Klose, S. M., Owusu, M., Nkrumah, E. E., Badu, E. K., Anti, P., Agbenyega, O., Meyer, B., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1903.121503 · Cited by 376
Inoue, Y., Tanaka, N., Tanaka, Y., Inoue, S., Morita, K., Zhuang, M., Hattori, T., & Sugamura, K. (2007) · Journal of Virology · doi:10.1128/jvi.00253-07 · Cited by 369
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Johansen, L. M., Brannan, J. M., Delos, S. E., Shoemaker, C. J., Stossel, A., Lear, C., Hoffstrom, B. G., DeWald, L. E., Schornberg, K. L., Scully, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005471 · Cited by 332
Self-citationInfectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway
Chu, J. J. H., & Ng, M. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10543-10555.2004 · Cited by 329
Perera, R. A., Wang, P., Gomaa, M. R., El-Shesheny, R., Kandeil, A., Bagato, O., Siu, L. Y., Shehata, M. M., Kayed, A. S., Moatasim, Y., et al. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.36.20574 · Cited by 323
Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.12.003 · Cited by 322
Bosch, B. J., Bartelink, W., & Rottier, P. J. M. (2008) · Journal of Virology · doi:10.1128/jvi.00415-08 · Cited by 315
Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992–2013
Corman, V. M., Jores, J., Meyer, B., Younan, M., Liljander, A., Said, M. Y., Gluecks, I., Lattwein, E., Bosch, B.-J., Drexler, J. F., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2008.140596 · Cited by 312
The WHO MERS-CoV Research Group (2013) · PLoS Currents · doi:10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8 · Cited by 309
A clinical drug library screen identifies astemizole as an antimalarial agent
Chong, C. R., Chen, X., Shi, L., Liu, J. O., & Sullivan, D. J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio806 · Cited by 289
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 273
Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013
Meyer, B., Müller, M. A., Corman, V. M., Reusken, C. B. E. M., Ritz, D., Godeke, G.-J., Lattwein, E., Kallies, S., Siemens, A., van Beek, J., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2004.131746 · Cited by 268
JC Virus Enters Human Glial Cells by Clathrin-Dependent Receptor-Mediated Endocytosis
Pho, M. T., Ashok, A., & Atwood, W. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2288-2292.2000 · Cited by 252
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
Madrid, P. B., Chopra, S., Manger, I. D., Gilfillan, L., Keepers, T. R., Shurtleff, A. C., Green, C. E., Iyer, L. V., Dilks, H. H., Davey, R. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060579 · Cited by 247
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary
Mackway-Jones, K. (2021) · Emergency Medicine Journal · doi:10.1136/emermed-2020-211011.1 · Cited by 218
Hart, B. J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Frieman, M. B., Holbrook, M. R., Jahrling, P. B., et al. (2014) · Journal of General Virology · doi:10.1099/vir.0.061911-0 · Cited by 211
Self-citationBarnard, D. L., Day, C. W., Bailey, K., Heiner, M., Montgomery, R., Lauridsen, L., Chan, P. K., & Sidwell, R. W. (2006) · Antiviral Chemistry and Chemotherapy · doi:10.1177/095632020601700505 · Cited by 210
Shoemaker, C. J., Schornberg, K. L., Delos, S. E., Scully, C., Pajouhesh, H., Olinger, G. G., Johansen, L. M., & White, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056265 · Cited by 147
Self-citationClose Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat
Heidarieh, P., Azarpira, S., Shojaei, H., Hashemzadeh, M. S., Tortoli, E., & África, S. (2013) · Cited by 144
Polyether ionophores—promising bioactive molecules for cancer therapy
Huczyński, A. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.046 · Cited by 134
Nawa, M., Takasaki, T., Yamada, K., Kurane, I., & Akatsuka, T. (2003) · Journal of General Virology · doi:10.1099/vir.0.18883-0 · Cited by 133
Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase
Garcia, M. L., Cooper, A., Shi, W., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003500 · Cited by 128
Joki‐Korpela, P., Marjomäki, V., Krogerus, C., Heino, J., & Hyypiä, T. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1958-1967.2001 · Cited by 112
Reeves, P. M., Smith, S. K., Olson, V. A., Thorne, S. H., Bornmann, W. G., Damon, I. K., & Kalman, D. (2010) · Journal of Virology · doi:10.1128/jvi.01814-10 · Cited by 98
Kumaki, Y., Wandersee, M. K., Smith, A., Zhou, Y., Simmons, G., Nelson, N. M., Bailey, K. W., Vest, Z. G., Li, J. K.-K., Chan, P. K. S., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.02.003 · Cited by 92
Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2
Koo, K. H., Kim, H., Bae, Y.-K., Kim, K., Park, B.-K., Lee, C.-H., & Kim, Y.-N. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.223 · Cited by 81
Effect of monensin on the assembly of Uukuniemi virus in the Golgi complex
Kuismanen, E., Saraste, J., & Pettersson, R. F. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.813-822.1985 · Cited by 60
Influence of chlorpromazine on the replication of influenza virus in chick embryo cells.
Križanová, O., ČIAMPOR, F. J., & Veber, P. (1982) · PubMed · Cited by 45
Cited by
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
Middle East respiratory syndrome
Zumla, A., Hui, D. S., & Perlman, S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60454-8 · Cited by 1,263
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Choy, K.-T., Wong, A. Y.-L., Kaewpreedee, P., Sia, S. F., Chen, D., Hui, K. P. Y., Chu, D. K. W., Chan, M. C. W., Cheung, P. P.-H., Huang, X., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104786 · Cited by 922
Metadata
- Authors
- Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., Johansen, L. M., Lear-Rooney, C. M., Glass, P. J., Hensley, L. E., & Frieman, M. B.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-08
- Volume
- 58
- Issue
- 8
- Pages
- 4885-4893
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2171353131
- Cited by
- 660
- References
- 46
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.